Literature DB >> 20106644

Synergistic effects of beta-aescin and 5-fluorouracil in human hepatocellular carcinoma SMMC-7721 cells.

Z J Ming1, Y Hu, Y H Qiu, L Cao, X G Zhang.   

Abstract

The effects and mechanisms of action of beta-aescin and 5-fluorouracil (5-FU), alone and in combination, were studied in human hepatocellular carcinoma SMMC-7721 cells. Growth inhibition, cell cycle distribution, apoptosis, Bcl-2 expression and caspase activity were assessed. The Isobole-method/interaction-index analysis was applied to evaluate the synergy, additivity or antagonism of these agents. The results indicate that mixtures of beta-aescin and 5-FU showed a synergistic effect on the 50% inhibitory effect when their ratio was 4:1 when compared with either agent alone. The mechanism of action could be through the synergistic arrest of the cell cycle, induction of apoptosis, activation of caspases-3, 8 and 9, and down-regulation Bcl-2 expression. The results suggest that mixtures of these two agents had a synergistic inhibitory effect on SMMC-7721 cells, an observation which might be useful for the further development of anti-cancer drugs. (c) 2009. Published by Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106644     DOI: 10.1016/j.phymed.2009.12.009

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  13 in total

1.  Anticancer effects of 5-fluorouracil combined with warming and relieving cold phlegm formula on human breast cancer.

Authors:  Xue-Lin Wang; Feng Ma; Xiong-Zhi Wu
Journal:  Chin J Integr Med       Date:  2011-12-08       Impact factor: 1.978

2.  Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.

Authors:  Yong-Wei Wang; Shuang-Jia Wang; Yi-Nan Zhou; Shang-Ha Pan; Bei Sun
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-24       Impact factor: 4.553

3.  Escin reduces cell proliferation and induces apoptosis on glioma and lung adenocarcinoma cell lines.

Authors:  Gülşen Akalin Çiftçi; Arzu Işcan; Mehtap Kutlu
Journal:  Cytotechnology       Date:  2015-04-24       Impact factor: 2.058

4.  Escin-induced DNA damage promotes escin-induced apoptosis in human colorectal cancer cells via p62 regulation of the ATM/γH2AX pathway.

Authors:  Zhong Wang; Qiang Chen; Bin Li; Jia-Ming Xie; Xiao-Dong Yang; Kui Zhao; Yong Wu; Zhen-Yu Ye; Zheng-Rong Chen; Zheng-Hong Qin; Chun-Gen Xing
Journal:  Acta Pharmacol Sin       Date:  2018-05-31       Impact factor: 6.150

5.  β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.

Authors:  Gui-Li Huang; Dong-Yan Shen; Cheng-Fu Cai; Qiu-Yan Zhang; Hong-Yue Ren; Qing-Xi Chen
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

6.  Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line.

Authors:  Rongrong Zhu; Xianzheng Wu; Yu Xiao; Bo Gao; Qian Xie; Hui Liu; Shilong Wang
Journal:  Cancer Biother Radiopharm       Date:  2013-06-29       Impact factor: 3.099

7.  Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis.

Authors:  Jiening Dun; Xueyan Chen; Haixia Gao; Yan Zhang; Huajun Zhang; Yongjian Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-02

8.  TIGAR knockdown enhanced the anticancer effect of aescin via regulating autophagy and apoptosis in colorectal cancer cells.

Authors:  Bin Li; Zhong Wang; Jia-Ming Xie; Gang Wang; Li-Qiang Qian; Xue-Mei Guan; Xue-Ping Shen; Zheng-Hong Qin; Gen-Hai Shen; Xiao-Qiang Li; Quan-Gen Gao
Journal:  Acta Pharmacol Sin       Date:  2018-05-16       Impact factor: 6.150

9.  Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells.

Authors:  Z Zhang; L Miao; C Lv; H Sun; S Wei; B Wang; C Huang; B Jiao
Journal:  Cell Death Dis       Date:  2013-06-06       Impact factor: 8.469

10.  Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell lines.

Authors:  Kazuya Uchibori; Atsushi Kasamatsu; Masahiko Sunaga; Satoshi Yokota; Tomoya Sakurada; Eriko Kobayashi; Masaharu Yoshikawa; Katsuhiro Uzawa; Shiro Ueda; Hideki Tanzawa; Nobunori Sato
Journal:  Int J Oncol       Date:  2011-12-15       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.